Epigenomics AG (ECXk)

Currency in EUR
0.88
-0.01(-1.12%)
Delayed Data·
Earnings results expected today
ECXk is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.880.88
52 wk Range
0.502.30
Key Statistics
Bid/Ask
0.88 / 1.48
Prev. Close
0.89
Open
0.88
Day's Range
0.88-0.88
52 wk Range
0.5-2.3
Volume
-
Average Volume (3m)
432
1-Year Change
-20.54%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ECXk Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Niche player in the %INDUSTRY% industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell

Epigenomics AG Company Profile

Epigenomics AG does not have significant operations. Previously, it was involved in liquid biopsy for the early detection of cancer. The company was founded in 1998 and is based in Heidelberg, Germany.

Compare ECXk to Peers and Sector

Metrics to compare
ECXk
Peers
Sector
Relationship
P/E Ratio
−0.3x−4.7x−0.6x
PEG Ratio
0.000.010.00
Price/Book
-1.2x2.6x
Price / LTM Sales
192.9x15.0x3.3x
Upside (Analyst Target)
-105.6%41.3%
Fair Value Upside
Unlock−8.0%4.9%Unlock

Earnings

Latest Release
Aug 29, 2025
EPS / Forecast
-0.23 / --
Revenue / Forecast
4.00K / --
EPS Revisions
Last 90 days

ECXk Income Statement

FAQ

What Stock Exchange Does Epigenomics Trade On?

Epigenomics is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Epigenomics?

The stock symbol for Epigenomics is "ECXk."

What Is the Epigenomics (ECXk) Afterhours Price Today? (Afterhours variable test: 0.00) Current Date: 14 Nov 2025

After hours price: 0.00. After hours price change (units): 0.00. Price change percentage: 0.00%

What Is the Epigenomics Market Cap?

As of today, Epigenomics market cap is 780.48K.

What Is Epigenomics's Earnings Per Share (TTM)?

The Epigenomics EPS (TTM) is -3.15.

When Is the Next Epigenomics Earnings Date?

Epigenomics will release its next earnings report on 13 Nov 2025.

From a Technical Analysis Perspective, Is ECXk a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Epigenomics Stock Split?

Epigenomics has split 9 times.

How Many Employees Does Epigenomics Have?

Epigenomics has 3 employees.

What is the current trading status of Epigenomics (ECXk)?

As of 14 Nov 2025, Epigenomics (ECXk) is trading at a price of 0.88, with a previous close of 0.89. The stock has fluctuated within a day range of 0.88 to 0.88, while its 52-week range spans from 0.50 to 2.30.

What Is the ECXk After Hours Price?

ECXk's last after hours stock price is 0.00, the stock has decreased by 0.00, or 0.00%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.